Εμφάνιση απλής εγγραφής

dc.creatorKalogeridi, M. A.en
dc.creatorKelekis, N.en
dc.creatorKouvaris, J.en
dc.creatorPlatoni, K.en
dc.creatorKyrias, G.en
dc.creatorPectasides, D.en
dc.creatorKouloulias, V.en
dc.date.accessioned2015-11-23T10:31:08Z
dc.date.available2015-11-23T10:31:08Z
dc.date.issued2009
dc.identifier10.2174/157488709789957583
dc.identifier.issn15748871
dc.identifier.urihttp://hdl.handle.net/11615/28786
dc.description.abstractLumpectomy followed by breast irradiation is an alternative to mastectomy for patients with early-stage breast cancer. The purpose of radiation treatment following lumpectomy is to minimize the risk of recurrent cancer in the treated breast with as little toxicity as possible so that good cosmesis and function are maintained. Conventional fractionation schedules for postlumpectomy radiotherapy give 50 Gy in 2 Gy daily fractions, often with an additional boost to the tumor bed, resulting in treatment being given over 5-7 weeks. Delivering postoperative radiotherapy in a shorter period of time, provided it is as effective as longer treatment regiments, could result in greater convenience for patients. Moreover, given the high incidence of breast cancer, the use of a shorter fractionation schedule would decrease waiting lists in busy radiotherapy departments. We searched the medline (pubmed) and we reviewed all the relevant publications. We concluded that the accelerated hypofractionated schedules are safe in terms of cosmesis and effective in terms of local control. © 2009 Bentham Science Publishers Ltd.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-73349089381&partnerID=40&md5=4ba7e11c9007ba0b91d8636508e0b48f
dc.subjectAdjuvant radiotherapyen
dc.subjectBreasten
dc.subjectCosmesisen
dc.subjectHypofractionationen
dc.subjectReviewen
dc.subjectToxicityen
dc.subjectamifostineen
dc.subjectbreast canceren
dc.subjectbreast diseaseen
dc.subjectcancer controlen
dc.subjectcancer radiotherapyen
dc.subjectcancer recurrenceen
dc.subjectcancer relapseen
dc.subjectcancer survivalen
dc.subjectclinical trialen
dc.subjectdisease durationen
dc.subjecthumanen
dc.subjectincidenceen
dc.subjectischemic heart diseaseen
dc.subjectlung fibrosisen
dc.subjectmorbidityen
dc.subjectoverall survivalen
dc.subjectpartial mastectomyen
dc.subjectpostoperative careen
dc.subjectpriority journalen
dc.subjectquality of lifeen
dc.subjectradiation dose fractionationen
dc.subjectrib fractureen
dc.subjectrisk factoren
dc.subjectskin toxicityen
dc.subjectBreast Neoplasmsen
dc.subjectClinical Trials as Topicen
dc.subjectCombined Modality Therapyen
dc.subjectDose Fractionationen
dc.subjectEstheticsen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMastectomy, Segmentalen
dc.subjectRadiotherapy Dosageen
dc.subjectRadiotherapy, Adjuvanten
dc.subjectSurvival Analysisen
dc.titleAccelerated hypofractionated radiotherapy schedules in breast cancer: A review of the current literatureen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής